This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Regulatory Requirements and Comparison of Approval of New and Generic Drugs in the United States of America and Japan: Implication for Future Strategies, Applied Drug Research Clinical Trials and Regulatory Affairs, May 2021, Bentham Science Publishers,
DOI: 10.2174/2213476x07666200808163247.
You can read the full text:
The following have contributed to this page
